These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31356286)

  • 1. Parkinson Disease.
    Zesiewicz TA
    Continuum (Minneap Minn); 2019 Aug; 25(4):896-918. PubMed ID: 31356286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Treatment of Parkinson Disease: A Review.
    Armstrong MJ; Okun MS
    JAMA; 2020 Feb; 323(6):548-560. PubMed ID: 32044947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety.
    Dhall R; Kreitzman DL
    Neurology; 2016 Apr; 86(14 Suppl 1):S13-24. PubMed ID: 27044646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):112. PubMed ID: 26218794
    [No Abstract]   [Full Text] [Related]  

  • 5. Enteral feeding in Parkinson's patients receiving levodopa/carbidopa intestinal gel.
    Bove F; Bentivoglio AR; Naranian T; Fasano A
    Parkinsonism Relat Disord; 2017 Sep; 42():109-111. PubMed ID: 28676196
    [No Abstract]   [Full Text] [Related]  

  • 6. Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR).
    Makela EH; Cutlip WD
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):234-5. PubMed ID: 1627988
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinson Disease: Current and Emerging Treatment Strategies.
    Ramirez-Zamora A
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29999254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A wrinkle in ON-time - A GI structural abnormality confounding levodopa therapy with Duodopa rescue; a case study.
    Staisch J; Bakis G; Nutt J
    Parkinsonism Relat Disord; 2018 May; 50():130-131. PubMed ID: 29478835
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled-release carbidopa/levodopa in the treatment of Parkinsonism.
    Hutton JT; Dippel RL; Bianchine JR; Strahlendorf HK; Meyer PG
    Clin Neuropharmacol; 1984; 7(2):135-9. PubMed ID: 6375861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
    Block G; Liss C; Reines S; Irr J; Nibbelink D
    Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa-carbidopa intestinal gel: 'dismantling the road blocks of a journey'.
    Vijiaratnam N; Sue CM
    Intern Med J; 2018 Apr; 48(4):472-474. PubMed ID: 29623993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease: recent advances in therapy.
    Jankovic J
    South Med J; 1988 Aug; 81(8):1021-7. PubMed ID: 3043683
    [No Abstract]   [Full Text] [Related]  

  • 13. Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease.
    Silver DE; Trosch RM
    Neurology; 2016 Apr; 86(14 Suppl 1):S25-35. PubMed ID: 27044647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".
    Lambarth AT
    CNS Drugs; 2016 Oct; 30(10):1007-8. PubMed ID: 27541607
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication.
    Salomone G; Marano M; di Biase L; Melgari JM; Di Lazzaro V
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1124-5. PubMed ID: 26242552
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Levodopa + Carbidopa on the Laryngeal Electromyographic Pattern in Parkinson Disease.
    Noffs G; de Campos Duprat A; Zarzur AP; Cury RG; Cataldo BO; Fonoff E
    J Voice; 2017 May; 31(3):383.e19-383.e23. PubMed ID: 27839704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jejunal catheter placement for levodopa-carbidopa infusion in a patient with Billroth I gastrectomy.
    Markos P; Bilic B; Miletic V; Rustemovic N
    Endoscopy; 2016; 48 Suppl 1():E288. PubMed ID: 27626213
    [No Abstract]   [Full Text] [Related]  

  • 18. Approach to the patient with Parkinson disease.
    Johnson KE
    Prim Care; 2015 Jun; 42(2):205-15. PubMed ID: 25979582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".
    Wirdefeldt K; Odin P; Nyholm D
    CNS Drugs; 2016 Oct; 30(10):1009-10. PubMed ID: 27541606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.